News about cell analysis instruments and tools including flow cytometry, cell counters, high content screening, etc.
BD FACSDuet™ Premium System Leverages Robotics to Automate Sample Preparation for Greater Standardization in Clinical Flow Cytometry Diagnostics FRANKLIN LAKES, N.J. , June 12, 2023 /PRNewswire/ — BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, Read more
WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced that it has added PerkinElmer Flow Cytometry Instrument Concierge Services to its OneSource® Laboratory Services portfolio. The comprehensive and flexible offering will provide biopharmaceutical labs with expert, onsite flow cytometry specialists to help manage their instruments and processes more efficiently... Read more
JULY 05, 2022 MINNEAPOLIS, July 5, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), today announced it has completed the acquisition of Namocell, Inc. The Namocell acquisition adds easy-to-use single cell sorting and dispensing platforms that are gentle to cells and preserve cell viability and integrity. Namocell’s instruments and consumables are critical technologies in various workflows in... Read more
JUNE 22, 2022 MINNEAPOLIS and MOUNTAIN VIEW, Mo., June 22, 2022 /PRNewswire/ — Bio-Techne Corporation (NASDAQ:TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced it has reached an agreement to acquire Namocell, Inc. Bio-Techne anticipates the acquisition to close in the first quarter of its... Read more
Developed with novel dye technology and AI guidance, new BD Horizon RealYellow™ 586 Reagents have potential to accelerate discovery and drug development in oncology, autoimmune disorders and infectious diseases FRANKLIN LAKES, N.J., April 25, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of... Read more
Next-gen 3D biology lab programs stem cells that differentiate and self-organize into organoid models with higher reproducibility and consistency for screening San Jose, Calif., April 12, 2022 – Molecular Devices, LLC., a leading provider of high-performance life science solutions, this month celebrates the one-year anniversary of its automated 3D imaging workcell, the Organoid Innovation Center, located at... Read more
FRANKLIN LAKES, N.J., Jan. 20, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that a study conducted in collaboration with the European Molecular Biology Laboratory (EMBL) and published as the cover story of the January 21st issue of the journal, Science, profiles a new BD... Read more
Flagship product from Honeycomb Biotechnologies advances single-cell profiling by enabling scientists to capture, store and study fragile cell types WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 18, 2021– PerkinElmer, Inc. (NYSE: PKI) and Honeycomb Biotechnologies, Inc., announced today the commercial launch of the first of its kind HIVETM scRNAseq Solution for single-cell isolation and analysis. The HIVE solution leverages a... Read more
Fremont, CA, September 20, 2021 — Life Science Newswire — Biotium, a leading supplier and inventor of fluorescent probes for life science research, announces the release of infrared CF®850 and CF®870 dyes. These novel long wavelength dyes are the first commercially available fluorescent dyes with emission maxima greater than 850 nm, allowing researchers to further investigate the “final... Read more
FRANKLIN LAKES, N.J., Aug. 11, 2021 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of a new benchtop cell analyzer that brings sophisticated flow cytometry capabilities to laboratories of all sizes. The new BD FACSymphony™ A1 Cell Analyzer is a fluorescence-activated cell analyzer that offers advanced... Read more